OKYO Pharma (FRA:OK10) Institutional Ownership: 0.02% (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OK10 OKYO Pharma Ltd FRA:OK10
24 GF Score
Price €1.36
! 2 Warning Signs
View Full Analysis

What is OKYO Pharma Institutional Ownership?

OKYO Pharma FRA:OK10 24 Institutional Ownership is 0.02% as of Aug. 09, 2026. GuruFocus rates FRA:OK10 with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OKYO Pharma's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OKYO Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OKYO Pharma's Float Percentage Of Total Shares Outstanding is 80.68%.

OKYO Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Institutional Ownership Chart

OKYO Pharma Historical Data

The historical data trend for OKYO Pharma can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.11 0.11 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02
FRA:OK10
24GF Score
OKYO Pharma Ltd FRA:OK10
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.02% mean?
OKYO Pharma (FRA:OK10) has a Institutional Ownership of 0.02% as of Aug. 09, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OKYO Pharma and its competitors.
Is OKYO Pharma's Institutional Ownership too high?
OKYO Pharma's current Institutional Ownership is 0.02%. Overall, OKYO Pharma has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Institutional Ownership compare to ALPS and CGTX?
OKYO Pharma's Institutional Ownership of 0.02% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current Institutional Ownership is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (FRA:OK10) has a current Institutional Ownership of 0.02%. The current Institutional Ownership is 0.02%. OKYO Pharma's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For OKYO Pharma (FRA:OK10), the current Institutional Ownership is 0.02% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Other Exchanges OKYO:USA
Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
24GF Score

Get the complete analysis for FRA:OK10

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.36
Price